Summary

The global market for Amoxicillin was estimated to be worth US$ 4925 million in 2024 and is forecast to a readjusted size of US$ 6162 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Amoxicillin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection. In this article, we study the amoxicillin drug. In 2024, global Amoxicillin production reached approximately 2897 m units, with an average global market price of around US$ 1.7 perunit.

Amoxicillin’s market opportunity is rooted in the expansion of primary healthcare systems globally and the persistent need for accessible, cost-effective antibiotics. Guidance from governments and international health bodies on managing common infections in primary care and pediatrics helps keep amoxicillin as a preferred listed medicine and within reimbursement schemes, supporting predictable procurement and distribution. Additionally, population aging and the management of chronic comorbid infections broaden antibiotic use across hospitals and outpatient settings, creating sustained market space and opportunities for manufacturers to build brand recognition.Despite steady demand, the amoxicillin market faces multiple risks including antimicrobial stewardship pressures, drug shortages, and pricing constraints from reimbursement systems. Stewardship policies tightening prescriptions in various countries can reduce unnecessary consumption; moreover, the concentration of suppliers for active pharmaceutical ingredients (APIs) and key intermediates, rising compliance costs, and global supply-chain volatility all threaten supply stability and margin profiles. Companies must balance compliance and quality with agile responses to policy and supply-side systemic risks. Downstream demand is evolving from traditional hospital prescriptions toward community healthcare, pediatrics, and online prescription channels, with reimbursement expansion and strengthened primary care capacity underpinning robust demand for oral formulations. At the same time, combination products and improved dosage forms (e.g., dispersible or child-friendly formulations) increase clinical convenience and present product-line extension opportunities for differentiation. In many emerging markets, the pace of essential-medicine substitution and formulary updates will determine the tempo of short-to-medium-term product mix adjustments and market entry strategies.

This report aims to provide a comprehensive presentation of the global market for Amoxicillin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Amoxicillin by region & country, by Type, and by Application.
The Amoxicillin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amoxicillin.

Market Segmentation
By Company
GSK
Novartis
Centrient Pharma
Teva
Viatris
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
Guangzhou Baiyunshan
Segment by Type
Capsule
Tablet
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Amoxicillin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Amoxicillin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Amoxicillin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Amoxicillin Product Introduction
1.2 Global Amoxicillin Market Size Forecast
1.2.1 Global Amoxicillin Sales Value (2020-2031)
1.2.2 Global Amoxicillin Sales Volume (2020-2031)
1.2.3 Global Amoxicillin Sales Price (2020-2031)
1.3 Amoxicillin Market Trends & Drivers
1.3.1 Amoxicillin Industry Trends
1.3.2 Amoxicillin Market Drivers & Opportunity
1.3.3 Amoxicillin Market Challenges
1.3.4 Amoxicillin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Amoxicillin Players Revenue Ranking (2024)
2.2 Global Amoxicillin Revenue by Company (2020-2025)
2.3 Global Amoxicillin Players Sales Volume Ranking (2024)
2.4 Global Amoxicillin Sales Volume by Company Players (2020-2025)
2.5 Global Amoxicillin Average Price by Company (2020-2025)
2.6 Key Manufacturers Amoxicillin Manufacturing Base and Headquarters
2.7 Key Manufacturers Amoxicillin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Amoxicillin
2.9 Amoxicillin Market Competitive Analysis
2.9.1 Amoxicillin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Amoxicillin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amoxicillin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Capsule
3.1.2 Tablet
3.1.3 Others
3.2 Global Amoxicillin Sales Value by Type
3.2.1 Global Amoxicillin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Amoxicillin Sales Value, by Type (2020-2031)
3.2.3 Global Amoxicillin Sales Value, by Type (%) (2020-2031)
3.3 Global Amoxicillin Sales Volume by Type
3.3.1 Global Amoxicillin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Amoxicillin Sales Volume, by Type (2020-2031)
3.3.3 Global Amoxicillin Sales Volume, by Type (%) (2020-2031)
3.4 Global Amoxicillin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Amoxicillin Sales Value by Application
4.2.1 Global Amoxicillin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Amoxicillin Sales Value, by Application (2020-2031)
4.2.3 Global Amoxicillin Sales Value, by Application (%) (2020-2031)
4.3 Global Amoxicillin Sales Volume by Application
4.3.1 Global Amoxicillin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Amoxicillin Sales Volume, by Application (2020-2031)
4.3.3 Global Amoxicillin Sales Volume, by Application (%) (2020-2031)
4.4 Global Amoxicillin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Amoxicillin Sales Value by Region
5.1.1 Global Amoxicillin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Amoxicillin Sales Value by Region (2020-2025)
5.1.3 Global Amoxicillin Sales Value by Region (2026-2031)
5.1.4 Global Amoxicillin Sales Value by Region (%), (2020-2031)
5.2 Global Amoxicillin Sales Volume by Region
5.2.1 Global Amoxicillin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Amoxicillin Sales Volume by Region (2020-2025)
5.2.3 Global Amoxicillin Sales Volume by Region (2026-2031)
5.2.4 Global Amoxicillin Sales Volume by Region (%), (2020-2031)
5.3 Global Amoxicillin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Amoxicillin Sales Value, 2020-2031
5.4.2 North America Amoxicillin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Amoxicillin Sales Value, 2020-2031
5.5.2 Europe Amoxicillin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Amoxicillin Sales Value, 2020-2031
5.6.2 Asia Pacific Amoxicillin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Amoxicillin Sales Value, 2020-2031
5.7.2 South America Amoxicillin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Amoxicillin Sales Value, 2020-2031
5.8.2 Middle East & Africa Amoxicillin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Amoxicillin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Amoxicillin Sales Value and Sales Volume
6.2.1 Key Countries/Regions Amoxicillin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Amoxicillin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Amoxicillin Sales Value, 2020-2031
6.3.2 United States Amoxicillin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Amoxicillin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Amoxicillin Sales Value, 2020-2031
6.4.2 Europe Amoxicillin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Amoxicillin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Amoxicillin Sales Value, 2020-2031
6.5.2 China Amoxicillin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Amoxicillin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Amoxicillin Sales Value, 2020-2031
6.6.2 Japan Amoxicillin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Amoxicillin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Amoxicillin Sales Value, 2020-2031
6.7.2 South Korea Amoxicillin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Amoxicillin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Amoxicillin Sales Value, 2020-2031
6.8.2 Southeast Asia Amoxicillin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Amoxicillin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Amoxicillin Sales Value, 2020-2031
6.9.2 India Amoxicillin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Amoxicillin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 GSK
7.1.1 GSK Company Information
7.1.2 GSK Introduction and Business Overview
7.1.3 GSK Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 GSK Amoxicillin Product Offerings
7.1.5 GSK Recent Development
7.2 Novartis
7.2.1 Novartis Company Information
7.2.2 Novartis Introduction and Business Overview
7.2.3 Novartis Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Novartis Amoxicillin Product Offerings
7.2.5 Novartis Recent Development
7.3 Centrient Pharma
7.3.1 Centrient Pharma Company Information
7.3.2 Centrient Pharma Introduction and Business Overview
7.3.3 Centrient Pharma Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Centrient Pharma Amoxicillin Product Offerings
7.3.5 Centrient Pharma Recent Development
7.4 Teva
7.4.1 Teva Company Information
7.4.2 Teva Introduction and Business Overview
7.4.3 Teva Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Teva Amoxicillin Product Offerings
7.4.5 Teva Recent Development
7.5 Viatris
7.5.1 Viatris Company Information
7.5.2 Viatris Introduction and Business Overview
7.5.3 Viatris Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Viatris Amoxicillin Product Offerings
7.5.5 Viatris Recent Development
7.6 Cipla
7.6.1 Cipla Company Information
7.6.2 Cipla Introduction and Business Overview
7.6.3 Cipla Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Cipla Amoxicillin Product Offerings
7.6.5 Cipla Recent Development
7.7 NCPC
7.7.1 NCPC Company Information
7.7.2 NCPC Introduction and Business Overview
7.7.3 NCPC Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 NCPC Amoxicillin Product Offerings
7.7.5 NCPC Recent Development
7.8 United Laboratories
7.8.1 United Laboratories Company Information
7.8.2 United Laboratories Introduction and Business Overview
7.8.3 United Laboratories Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 United Laboratories Amoxicillin Product Offerings
7.8.5 United Laboratories Recent Development
7.9 Sun Pharma
7.9.1 Sun Pharma Company Information
7.9.2 Sun Pharma Introduction and Business Overview
7.9.3 Sun Pharma Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Sun Pharma Amoxicillin Product Offerings
7.9.5 Sun Pharma Recent Development
7.10 CSPC
7.10.1 CSPC Company Information
7.10.2 CSPC Introduction and Business Overview
7.10.3 CSPC Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 CSPC Amoxicillin Product Offerings
7.10.5 CSPC Recent Development
7.11 LKPC
7.11.1 LKPC Company Information
7.11.2 LKPC Introduction and Business Overview
7.11.3 LKPC Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 LKPC Amoxicillin Product Offerings
7.11.5 LKPC Recent Development
7.12 Hikma
7.12.1 Hikma Company Information
7.12.2 Hikma Introduction and Business Overview
7.12.3 Hikma Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Hikma Amoxicillin Product Offerings
7.12.5 Hikma Recent Development
7.13 Dr. Reddy
7.13.1 Dr. Reddy Company Information
7.13.2 Dr. Reddy Introduction and Business Overview
7.13.3 Dr. Reddy Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Dr. Reddy Amoxicillin Product Offerings
7.13.5 Dr. Reddy Recent Development
7.14 HPGC
7.14.1 HPGC Company Information
7.14.2 HPGC Introduction and Business Overview
7.14.3 HPGC Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 HPGC Amoxicillin Product Offerings
7.14.5 HPGC Recent Development
7.15 Aurubindo
7.15.1 Aurubindo Company Information
7.15.2 Aurubindo Introduction and Business Overview
7.15.3 Aurubindo Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Aurubindo Amoxicillin Product Offerings
7.15.5 Aurubindo Recent Development
7.16 Meiji Holdings
7.16.1 Meiji Holdings Company Information
7.16.2 Meiji Holdings Introduction and Business Overview
7.16.3 Meiji Holdings Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Meiji Holdings Amoxicillin Product Offerings
7.16.5 Meiji Holdings Recent Development
7.17 Guangzhou Baiyunshan
7.17.1 Guangzhou Baiyunshan Company Information
7.17.2 Guangzhou Baiyunshan Introduction and Business Overview
7.17.3 Guangzhou Baiyunshan Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Guangzhou Baiyunshan Amoxicillin Product Offerings
7.17.5 Guangzhou Baiyunshan Recent Development
8 Industry Chain Analysis
8.1 Amoxicillin Industrial Chain
8.2 Amoxicillin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Amoxicillin Sales Model
8.5.2 Sales Channel
8.5.3 Amoxicillin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer